WST West Pharmaceutical Services, Inc.

396.69USD-1.81%Mkt Cap: 27.63B USDP/E: 44.52

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap27.63B USD
Enterprise Value27.99B USD
Revenue (TTM)3.40B USD
Gross Profit1.10B USD
Net Income (TTM)493.70M USD
Revenue/Share47.57 USD
Last Price396.69 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees10.0K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)44.52
P/E (Forward)38.17
PEG2.94
EV/EBITDA29.12
EV/Revenue8.24
P/S8.14
P/B9.33
EPS (TTM)8.91 USD
EPS (Forward)10.39 USD
52W Range
223.8381% of range438.26
52W High438.26 USD
52W Low223.83 USD
Profitability
Gross Margin35.91%
Oper. Margin22.88%
EBITDA Margin28.30%
Profit Margin16.06%
ROE15.54%
ROA11.56%
ROIC18.75%
ROCE17.60%
Growth
Revenue Growth8.70%
Earnings Growth57.30%
Cash Flow & Leverage
Operating CF754.80M USD
CapEx (TTM)285.90M USD
FCF Margin10.17%
FCF Yield1.25%
Net Debt-150.20M USD
Net Debt/EBITDA-0.16
Net Debt/FCF-0.43
Balance Sheet
Debt/Equity0.10
Current Ratio2.82
Quick Ratio1.91
Book Value/Sh42.52 USD
Cash/Share6.66 USD
Dividends
Fwd Div Rate1.04 USD
Trail. Div Rate0.88 USD
Div. Yield0.26%
5Y Avg Yield0.25%
Payout Ratio9.88%
Ex-Div DateNov 10, 2026
Pay DateNov 18, 2026
Splits
Last Split2:1
Split DateSep 27, 2013
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)471.00 USD
Upside (mean)+18.7%
Target Range340.00 USD – 500.00 USD
340.00+18.7% to mean500.00
# Analysts15
Ownership
Shares Out.69.66M
Float69.13M
Insiders0.71%
Institutions102.29%
Short Interest
Short Ratio2.9d
Short % Float3.04%
Short % Out.2.59%
Shares Short1.81M
Short (prev mo.)2.10M
Technical
SMA 50381.73 (+3.9%)
SMA 200322.32 (+23.1%)
Beta1.14
S&P 52W Chg12.08%
Avg Vol (30d)669.36K
Avg Vol (10d)635.46K
Technical Indicators
RSI (14)47.5
MACD6.6618
MACD Signal8.8502
MACD Hist.-2.1884
BB Upper423.44 USD
BB Middle406.64 USD
BB Lower389.85 USD
BB Width8.26%
ATR (14)10.82 USD
Vol Ratio (20d)1.07x

About West Pharmaceutical Services (NYSE: WST)

›

West Pharmaceutical Services (NYSE: WST) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 10,000 employees.

The shares were at 396.69 USD on 19 November 2026, up 51.4% over 52 weeks. Its 52-week range is 223.83 USD to 438.26 USD: the price is 9.5% below the high and 77.2% above the low.

At a market capitalisation of 27.63B USD, it trades at 44.5 times trailing earnings and 38.2 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 51.8, a discount of 14% for WST. It pays a dividend yielding 0.26% (it pays out 10% of its earnings), against a median of 1.00% among the dividend payers in that peer group.

West Pharmaceutical Services reports return on equity of 15.5%, an operating margin of 22.9% and revenue up 8.7% year over year.

It holds more cash than debt, a net cash position of 150.20M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 15 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 471.00 USD is 18.7% above the current price. The next earnings report is expected on 18 February 2027.